Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMBR | P28336 | 1/20 | 0.44 |
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.42 |
| ▸ | REN | P00797 | 5/20 | 0.41 |
| ▸ | PSMB10 | P40306 | 1/20 | 0.39 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30665993 | 0.92 | NMBR (0.44) | NMBRSIRT2CTSS | |
| SCHEMBL30107538 | 0.92 | SIRT2 (0.44) | NMBRSIRT2REN | |
| SCHEMBL30107533 | 0.90 | REN (0.41) | NMBRSIRT2REN | |
| SCHEMBL31094878 | 0.90 | SIRT2 (0.41) | NMBRSIRT2 | |
| SCHEMBL30250367 | 0.89 | NMBR (0.42) | NMBRSIRT2CTSS | |
| SCHEMBL29427176 | 0.88 | NMBR (0.51) | NMBRSIRT2CTSS | |
| SCHEMBL29427178 | 0.88 | NMBR (0.51) | NMBRSIRT2CTSS | |
| SCHEMBL31614440 | 0.86 | REN (0.41) | RENPSMB10PSMB2 | |
| SCHEMBL29475292 | 0.84 | NMBR (0.40) | NMBRSIRT2RENCTSS | |
| SCHEMBL30053690 | 0.83 | NMBR (0.49) | NMBRSIRT2CTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441760-B2 | Amino diacids containing peptide modifiers | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2025-10-14 | — | — | US | disclosed |
| US-20240002433-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2024-01-04 | — | — | US | disclosed |
| US-11634455-B2 | Amino diacids containing peptide modifiers | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2023-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441760-B2 | Amino diacids containing peptide modifiers | PTMS, PEPD, NGLY1 | NMBR 1681/4885SIRT2 3109/4885REN 141/4885 |
| US-11634455-B2 | Amino diacids containing peptide modifiers | PTMS, PEPD, VIP | NMBR 1654/4885SIRT2 3138/4885REN 133/4885 |
| US-20240002433-A1 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | PTMS, PEPD, NGLY1 | NMBR 1681/4885SIRT2 3109/4885REN 141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.